15218298

Source:http://linkedlifedata.com/resource/pubmed/id/15218298

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0030705, umls-concept:C0045093, umls-concept:C0205179, umls-concept:C0205195, umls-concept:C0235974, umls-concept:C0246415, umls-concept:C0282460, umls-concept:C1512162
pubmed:issue	4
pubmed:dateCreated	2004-6-25
pubmed:abstractText	Responses have been observed in several studies of docetaxel as treatment for advanced pancreatic carcinoma. This trial was designed to determine if the addition of docetaxel to gemcitabine therapy produced responses in >/=25% of patients with chemonaive advanced pancreatic cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA17145, http://linkedlifedata.com/resource/pubmed/grant/CA21076, http://linkedlifedata.com/resource/pubmed/grant/CA21115, http://linkedlifedata.com/resource/pubmed/grant/CA23318, http://linkedlifedata.com/resource/pubmed/grant/CA49957, http://linkedlifedata.com/resource/pubmed/grant/CA66636, http://linkedlifedata.com/resource/pubmed/grant/CA80775
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0135054
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:issn	0030-2414
pubmed:author	pubmed-author:AvilesVictorV, pubmed-author:BensonAl BowenAB3rd, pubmed-author:BerlinJordan DJD, pubmed-author:HarrisJules EJE, pubmed-author:LevyDonna EDE, pubmed-author:ShepardRobert CRC, pubmed-author:StuartKeithK, pubmed-author:ThomasJames PJP
pubmed:copyrightInfo	Copyright 2004 S. Karger AG, Basel
pubmed:issnType	Print
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	303-9
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15218298-Adult, pubmed-meshheading:15218298-Aged, pubmed-meshheading:15218298-Antimetabolites, Antineoplastic, pubmed-meshheading:15218298-Antineoplastic Agents, Phytogenic, pubmed-meshheading:15218298-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15218298-Carcinoma, pubmed-meshheading:15218298-Deoxycytidine, pubmed-meshheading:15218298-Disease-Free Survival, pubmed-meshheading:15218298-Drug Administration Schedule, pubmed-meshheading:15218298-Female, pubmed-meshheading:15218298-Humans, pubmed-meshheading:15218298-Infusions, Intravenous, pubmed-meshheading:15218298-Male, pubmed-meshheading:15218298-Middle Aged, pubmed-meshheading:15218298-Pancreatic Neoplasms, pubmed-meshheading:15218298-Survival Analysis, pubmed-meshheading:15218298-Taxoids, pubmed-meshheading:15218298-Treatment Failure, pubmed-meshheading:15218298-United States
pubmed:year	2004
pubmed:articleTitle	Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.
pubmed:affiliation	University of Virginia, Charlottesville, Va., USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Multicenter Study, Clinical Trial, Phase II